A vast rate increase in the Mitsunobu reaction of phenols with alcohols where either or both are sterically hindered has been achieved by the use of high concentration combined with sonication.
The synthesis of (−)-stipiamide (1) is reported
together with the designed enynes 2
(6,7-dehydrostipiamide)
and 3 that are now shown to reverse the multidrug resistance
(MDR) of human breast cancer cells (MCF-7adrR).
Stipiamide was assembled using a Stille coupling with
(E)-vinyl iodide 17 and (Z)-stannyl
amide 16 in 78% yield.
(E)-Vinyl iodide 17 was made using a Takai
reaction and a selective dihydroxylation of the terminal olefin
of
nonconjugated diene 7 using the Sharpless AD-mix reagent.
The precursor to 16, (E,Z)-stannyl diene
ester 13, was
assembled with high selectivity in a single operation using a tandem
syn-addition of tributyltin cuprate to
acetylene
followed by conjugate addition to ethyl propiolate. Structural
variants 2 and 3 were assembled using
palladium-catalyzed Sonogashira couplings with vinyl iodides 17 and
35 and acetylenes 22 and 26 in high
yield at near 1:1
stoichiometry. Compound 2 was found to be far less
toxic than stipiamide and performed much better as an MDR
reversal agent. Compound 3 was better still due to even
lower toxicity.
The addition of carbamate nitrogen to a non-conjugated carbon-carbon triple bond is catalyzed by an ammonium salt leading to a cyclic product. Studies in homogeneous systems suggest that the ammonium agent facilitates nitrogen-carbon bond formation through a cation-π interaction with the alkyne unit that, for the first time, is directly observed by Raman spectroscopy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.